Business
Nanox to Report Fourth Quarter and Full Year 2021 Results on March 31, 2022
NEVE ILAN, Israel--(BUSINESS WIRE)-- NANO-X IMAGING LTD ("Nanox" or the "Company," Nasdaq: NNOX) will report its results for the fourth quarter and full year
About this update from Nano-x Imaging Ltd
[{"type":"text","content":" NEVE ILAN, Israel--(BUSINESS WIRE)--\nNANO-X IMAGING LTD (\"Nanox\" or the \"Company,\" Nasdaq: NNOX) will report its results for the fourth quarter and full year ended December 31, 2021 before market on Thursday, March 31, 2022. Erez Meltzer, Chief Executive Officer, and Ran Daniel, Chief Financial Officer, will host a conference call to review these results and provide a business update beginning at 8:30 a.m. ET.\n\nInterested parties may access the conference call by dialing (877) 550-3765 (Domestic) or (409) 937-8962 (International) and reference Access Code 5583017. Participants wishing to join the call via webcast may use the following webcast link: Nanox Q4 2021 Earnings. The link will also be posted in the Investor Relations section of the Nanox website at Events and Presentations. A replay of the webcast will be available shortly after the event concludes.\n\nAbout Nanox\n\nNanox, founded by the serial entrepreneur Ran Poliakine, is an Israeli corporation developing a commercial-grade digital X-ray source designed to be used in real-world medical imaging applications. Nanox believes that its novel technology could significantly reduce the costs of medical imaging systems and plans to seek collaborations with world-leading healthcare organizations and companies to provide affordable, early detection imaging services for all. For more information, please visit www.nanox.vision.\n\nForward-Looking Statements\n\nThis press release may contain forward-looking statements that are subject to risks and uncertainties. All statements that are not historical facts contained in this press release are forward-looking statements. Such statements include, but are not limited to, any statements relating to the initiation, timing, progress and results of the Company's research and development, manufacturing and commercialization activities with respect to its X-ray source technology and the Nanox.ARC, the ability to realize the expected benefits of the acquisitions, and the projected business prospects of the Company and the acquired companies. In some cases, you can identify forward-looking statements by terminology such as “can,” “might,” “believe,” “may,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “should,” “could,” “expect,” “predict,” “potential,” or the negative of these terms or other similar expressions. ...